1 A Process audit attempting to identify current practise of the use of low aspirin in patients with angina, cerebrovascular accident and myocardial infarction by case review
2 A trial fibrillation and the use of anti-thrombotic prophylaxis in general practice
3 A study to assess the efficacy of opportunistic health promotion in the waiting area of a general practice
4 To investigate the documented use of aspirin in secondary prevention following myocardial infarction in one Northumberland general practice following the publication of local guidelines, and to discover if improvements in use can be made.
5 An audit to assess whether the prescribing of H2Antagonists and proton pump inhibitors to patients over the age of 45 years in a general practice is in accordance with established clinical guidelines
6 An audit of secondary prevention after myocardial infarction
7 An audit of the anticoagulation therapy of patients in a rural practice
8 An audit of influenza vaccine uptake
9 Anticoagulant therapy in elderly patients with atrial fibrillation in general practice and prevention of stroke
10 Audit of cholesterol assay and treatment in patients with coronary heart disease
11 Frequency and quality of reviews of patients with epilepsy
12 The appropriate prescribing of iron supplements
13 Discover whether current use of proton pump inhibitors and H2-Antagonists in a general practice conforms to standard guidelines
14 Audit of thyroid function testing in patients with hypothyroidism receiving replacement thyroxine
15 Topical beta-blockers as a treatment for glaucoma: are they being avoided in patients with reversible airways disease?
16 Looking at how the patients receiving warfarin in my training practice had the important facts about their anticoagulation recorded
17 Management guidelines for patients with functional or anatomic asplenia
18 The secondary prevention of hypercholesterolaemia in patients following coronary artery surgery
19 The use of midstream urine specimens (MSUs) in general practice
20 The prescribing of the combined oral contraceptive pill in women over 35 years of age who smoke – are we adhering to current guidelines?
21 Secondary prevention of ischaemic heart disease – an audit of hyperlipidaemia detection and management in a training practice
22 Royal college of general practitioners clinical guidelines for the management of low back pain: How closely are the guidelines being followed?
23 HbA1c results in known diabetics of the practice to ascertain if monitoring activity is adequate and treatment is achieving currently recommended target levels
24 Causes and effects of "Lost notes" episodes in general practice
25 Recording of Smoking status and smoking cessation advice
26 Are patients with a diagnosis of depression on therapeutic doses of tricyclic antidepressants, and is treatment maintained for an adequate length of time? An audit of one GP
27 Monitoring patients on thyroid replacement therapy
28 Use of Eradication for helicobacter in endoscopically proven peptic ulcer disease
29 Auditing the treatment of patients with duodenal ulcers against evidence based guidelines
30 An audit of prescribing of aspirin and beta blockers post MI
31 Patients waiting time for routine non-urgent appointments
32 Management of hypothyroidism in my practice
33 MMR-1 uptake audit in a NE of England GP Practice and ways of improving the uptake
34 A practice based audit of the control of hypertension in patients aged between 30 and 75 who have type 2 diabetes mellitus
35 Identify all male patients registered with the practice, between the ages of forty and sixty, with known ischaemic heart disease, to ascertain if they have been assessed for evidence of hypercholesterolaemia within the last 12 months
36 Documentation of folic acid supplements for pregnant women
37 The management of depression in GP – an audit of documentation, follow-up and length of treatment with anti-depressant medication
38 The management of patients with epilepsy in a General Practice
39 Recorded data for aspirin prophylaxis in patients with Ischaemic Heart Disease
40 Follow up of patients on long term throxine replacement therapy usinf annual thyroid stimulating hormone levels (TSH)
41 Frequency that thyroid function tests had been checked in patients prescribed thyroxine
42 Long term, low dose proton pump inhibitor (PPI) prescribing in gastro-oesophagel reflux disease (GORD)
43 Proportion of pregnant women in our practice who smoke and to see whether the GP and community midwife had provided verbal and written information on the risks of smoking
44 Secondary prevention of ischaemic heart disease in patients under 70 years of age
45 How many people with hypertension and who are on bendrofluazide have had their electrolytes measured within the last year
46 Diagnosis and management of genital chlamydia infections
47 Notes of patients to assess management of continuing anti-coagulant therapy with warfarin in GP
48 Are statins used appropriately for patients at highest risk of coronary heart disease?
49 Payments received for contraceptive services provided by a GP
50 How may hypertensive patients have had their blood pressure measured in last six months?
51 Urea and electrolyte (U&E) testing in patients taking furosemide and digoxin
52 Combined oral contraception follow up in established pill users in GP
53 Lipid screening and management in patients with established coronary heart disease
54 The provision of family planning advice in a semi-rural practice
55 Thromboembolism prophylaxos in atrial fibrillation - are the patients in the practice with a diagnosis of atrial fibrillation receiving prophylaxis when appropriate
56 Are antibiotics prescribed to children consulting with upper respiratory tract infections
57 Folic acid supplemention in pregnancy for prevention of neural tube defect
58 Patient understanding of and compliance with prescribed inhaled corticosteroids
59 Repeat prescribing in an urban fund-holding practice
60 All patients who have suffered a myocardial infarction (MI) should have a blood cholesterol taken as part of their post-MI management
61 Management of patients after a myocardial infarct on lipid lowering drugs
62 Practice’s compliance with elements of an agreed protocol for the management of ischaemic heart disease
63 How well are we supporting and educating the epileptic patients in our practice? An audit of the information provided to epileptic patients about their condition
64 Are patients with congestive heart failure in general practice receiving angiotension converting enzyme (ACE) inhibitor therapy?
65 The incidence of patients with known hypercholesterolaemia not treated with drug therapy in the population covered by a general practice
66 Monitoring of thyroid and liver function in those patients on amiodarone in general practice
67 Management of patients with gout
68 Assessment of the monitoring of elderly patients with diabetes by annual review in residential homes compared with practice population
69 Amiodarone therapy and its monitoring in general practice: the necessity for guidelines to detect drug related adverse effects
70 Patients admitted as a medical emergency with a diagnosis of asthma, their attendance at the practice asthma clinic and their possession of a written self management plan